By Rachel Stone ( May 4, 2020, 6:32 PM EDT) -- A class of Suboxone buyers has urged the Third Circuit to reject Indivior's request to undo class certification for drug wholesalers accusing the drugmaker of employing a product-hopping scheme to maintain a monopoly on the opioid drug, in light of a recent case revoking certification of a class of buyers of the drug Lamictal....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.